Interestingly, in the HT-1376 bladder cancer cell line, the potentiation of birinapant and gemcitabine treatment was not attenuated by co-treatment with an anti-TNF antibody, thus indicating that the increase in cell death was via a TNF-independent-mechanism in this tumor [67]. This evidence concerns the gene TNF and urinary bladder carcinoma.